Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

J&J will export more COVID-19 vaccines to South Africa beyond 300,000 doses already promised - Aspen CEO

1 minute read

An Aspen Pharmacare logo is seen at outside company offices in Woodmead, Johannesburg, South Africa, September 13, 2018. REUTERS/Siphiwe Sibeko/File Photo

JOHANNESBURG, June 14 (Reuters) - Johnson & Johnson (JNJ.N) will be exporting more ready-to-administer doses to the South African government beyond the 300,000 that was been announced by the local drug regulator on Sunday, CEO of Aspen Pharmacare (APNJ.J) said on Monday.

Aspen is the local manufacturer of J&J's COVID-19 vaccine.

Reporting by Promit Mukherjee; Editing by Emma Rumney

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters